Evonik's China API plant operational
Evonik says new active pharmaceutical ingredient (API) plant in China is part of horizontal integration strategy.
Archives for May 2, 2010
Freeslate enters into strategic partnership with J&J
Freeslate has entered into a strategic partnership with Johnson and Johnson (J&J) to provide the pharma with integrated workflows, software and research services until 2012.
USTR lists counterfeit drug hotspots in annual report
The Office of the United States Trade Representative (USTR) has expressed particular concern about the proliferation of counterfeit drugs in countries including Brazil, China, India, Indonesia and Russia.
DSM joins with Australian government for biologics plant
DSM Biologics has entered into a partnership with the Australian government to build a 70,000 sq ft biopharmaceutical contract manufacturing facility.
EyeGate, GSK collaborate on ocular delivery of drugs
EyeGate Pharma is collaborating with GlaxoSmithKline (GSK) to evaluate the delivery if several of the big pharma’s therapies using an ocular delivery system.
BioFocus, CHDI collaborate to target Huntingdon’s
BioFocus is expanding its Huntingdon’s disease collaboration with CHDI by committing to take targets it developed in its earlier deal, through discovery as part of a five year, $41m (€31m) agreement.